黑料吃瓜群网

Don't Rush to Crush+ — the new digital edition


Monday, 17 March, 2025


<em>Don&#39;t Rush to Crush+</em> &mdash; the new digital edition

has released a fully digital edition, , expanding accessibility and ensuring regular updates to support healthcare professionals. This trusted resource, included in the Pharmacy Board of Australia鈥檚 essential reference list, now provides comprehensive information on more than 600 oral medicines available in Australia. It is accessible via the eMIMS and AusDI platforms, offering an efficient and convenient way for pharmacists, nurses, speech pathologists and other healthcare providers to access critical information.

The transition to a fully digital format reflects the evolving needs of health professionals who rely on up-to-date, easily accessible data. This shift allows for a more flexible presentation of monographs and a more agile response to new developments in medication safety. Updates will now be released quarterly, focusing on a different therapeutic class each time. While the digital edition is now the primary format, we recognise the importance of accessibility. Don鈥檛 Rush to Crush+ may still be printed on demand, ensuring that all users can access this vital information in a way that best suits their needs.

This transition also reflects a commitment to environmental sustainability, reducing unnecessary printing while maintaining essential healthcare support. Dr Lisa Pont, Chair of the Don鈥檛 Rush to Crush Editorial Committee, highlights the enhanced focus on patient safety in this first digital edition: 鈥淚n collaboration with the University of Tasmania鈥檚 Department of Pharmacy and Pharmacology, our most extensive dispersion testing to date has informed the latest recommendations, with more than 160 medicines assessed for their suitability for administration via enteral feeding tubes.鈥

An additional 150 medicines are currently undergoing testing, ensuring that future updates remain evidence-based and clinically relevant. Moreover, the new edition introduces a clear identification of large tablets and capsules, addressing growing concerns about choking risks 鈥 even for individuals without diagnosed swallowing difficulties. With this transition, Don鈥檛 Rush to Crush+ continues to be an indispensable tool for Australian healthcare professionals, supporting safe and informed medication administration. It is now available via the and platforms, ensuring seamless access to the latest guidance on oral medicine administration. Learn more at .

Kristin Michaels, Chief Executive Officer of Advanced Pharmacy Australia.

Top image credit: iStock.com/ediebloom

Related Articles

Could this strategy mark a turning point in the HIV-cure search?

A team of Australian researchers have repurposed the same mRNA delivery system used in COVID-19...

Key concerns this Sarcoma Awareness Month

July is Sarcoma Awareness Month, and the Australia and New Zealand Sarcoma Association has raised...

Queensland gains private hospital surgery for lymphoedema

Greenslopes Private 黑料吃瓜群网 in Brisbane now offers advanced microsurgery for lymphoedema,...



Content from other channels on our network


  • All content Copyright 漏 2025 黑料吃瓜群网-Farrow Pty Ltd